Violation Tracker Parent Company Summary

Parent Company Name: 
GlaxoSmithKline
Ownership Structure: 
publicly traded (ticker symbol GSK)
Headquartered in: 
United Kingdom
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$7,822,200,258
Number of records: 
34
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
financial offenses$3,400,000,0001
healthcare-related offenses$3,004,361,8604
safety-related offenses$880,809,5005
government-contracting-related offenses$383,656,21612
competition-related offenses$152,500,0005
Top 5 Primary Offense TypesPenalty TotalNumber of Records
tax violations$3,400,000,0001
off-label or unapproved promotion of medical products$3,004,361,8604
drug or medical equipment safety violation$880,750,0004
False Claims Act and related$383,656,21612
kickbacks and bribery$125,000,0002
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Primary Offense Type Year Agency Penalty Amountsort icon
GLAXOSMITHKLINE LLC environmental violation 2016 PA-ENV $5,259
GlaxoSmithKline LLC environmental violation 2015 NY-ENV $24,200
GLAXO SMITH KLINE aviation safety violation 2014 FAA $59,500
GlaxoSmithKline Vaccines environmental violation 2014 EPA $172,900
GLAXOSMITHKLINE VACCINES environmental violation 2014 EPA (*) $172,900
GlaxoSmithKline LLC environmental violation 2014 EPA $317,550
GLAXOSMITHKLINE, LLC environmental violation 2014 EPA (*) $317,550
Block Drug Company Incorporated wage and hour violation 2011 WHD $352,773
GlaxoSmithKline False Claims Act and related 2006 GA-AG $418,952
GlaxoSmithKline off-label or unapproved promotion of medical products 2009 KY-AG $661,860
SmithKline Beecham Corp. False Claims Act and related 2007 TX-AG $1,400,000
GlaxoSmithKline False Claims Act and related 2012 ID-AG $2,600,000
GlaxoSmithKline LLC False Claims Act and related 2010 HI-AG $3,333,333
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $3,500,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2010 KY-AG $3,700,000
GlaxoSmithKline False Claims Act and related 2011 KS-AG $4,250,000
GlaxoSmithKline False Claims Act and related 2005 MULTI-AG (*) $10,000,000
GlaxoSmithKline False Claims Act and related 2012 LA-AG $10,000,000
SmithKline Beecham Corp. price-fixing or anti-competitive practices 2005 MULTI-AG $10,000,000
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $14,000,000
GlaxoSmithKline plc kickbacks and bribery 2016 SEC $20,000,000
GlaxoSmithKline False Claims Act and related 2003 MULTI-AG $40,000,000
GlaxoSmithKline, LLC drug or medical equipment safety violation 2011 MULTI-AG $40,750,000
SmithKline Beecham False Claims Act and related 2003 DOJ_CIVIL $47,000,000
GlaxoSmithKline LLC False Claims Act and related 2019 IL-AG $54,653,931
GlaxoSmithKline False Claims Act and related 2006 MULTI-AG $70,000,000
GlaxoSmithKline LLC drug or medical equipment safety violation 2012 MULTI-AG $90,000,000
GlaxoSmithKline, LLC kickbacks and bribery 2014 MULTI-AG $105,000,000
GlaxoSmithKline False Claims Act and related 2005 DOJ_CIVIL $150,000,000
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 MULTI-AG (*) $163,560,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $477,792,391
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 FDA $750,000,000
GlaxoSmithKline LLC off-label or unapproved promotion of medical products 2012 FDA $3,000,000,000
GlaxoSmithKline Holdings (Americas) tax violations 2006 IRS $3,400,000,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)